Royal Bank of Canada set a $94.00 target price on Walgreens Boots Alliance (NASDAQ:WBA) in a research report sent to investors on Friday morning. The firm currently has a buy rating on the pharmacy operator’s stock.
Several other research analysts also recently issued reports on WBA. Loop Capital set a $90.00 price objective on shares of Walgreens Boots Alliance and gave the stock a buy rating in a report on Tuesday, February 13th. Zacks Investment Research upgraded shares of Walgreens Boots Alliance from a hold rating to a buy rating and set a $76.00 price objective on the stock in a report on Wednesday, February 14th. BidaskClub upgraded shares of Walgreens Boots Alliance from a sell rating to a hold rating in a report on Wednesday, January 10th. Needham & Company LLC restated a buy rating and set a $88.00 price objective (up previously from $86.00) on shares of Walgreens Boots Alliance in a report on Wednesday, January 10th. Finally, Vetr downgraded shares of Walgreens Boots Alliance from a strong-buy rating to a buy rating in a report on Friday, December 1st. Ten analysts have rated the stock with a hold rating, twelve have given a buy rating and one has issued a strong buy rating to the stock. Walgreens Boots Alliance presently has a consensus rating of Buy and a consensus target price of $85.37.
Walgreens Boots Alliance (NASDAQ:WBA) opened at $70.92 on Friday. The company has a market cap of $70,260.00, a price-to-earnings ratio of 19.59, a P/E/G ratio of 1.19 and a beta of 1.18. Walgreens Boots Alliance has a twelve month low of $63.82 and a twelve month high of $88.00. The company has a quick ratio of 0.47, a current ratio of 0.96 and a debt-to-equity ratio of 0.48.
Walgreens Boots Alliance (NASDAQ:WBA) last announced its earnings results on Thursday, January 4th. The pharmacy operator reported $1.28 EPS for the quarter, topping the consensus estimate of $1.27 by $0.01. The firm had revenue of $30.74 billion for the quarter, compared to the consensus estimate of $30.39 billion. Walgreens Boots Alliance had a net margin of 3.19% and a return on equity of 19.15%. The business’s quarterly revenue was up 7.9% on a year-over-year basis. During the same quarter last year, the firm posted $1.10 EPS. analysts expect that Walgreens Boots Alliance will post 5.73 earnings per share for the current fiscal year.
The firm also recently announced a quarterly dividend, which will be paid on Monday, March 12th. Stockholders of record on Thursday, February 15th will be given a dividend of $0.40 per share. The ex-dividend date of this dividend is Wednesday, February 14th. This represents a $1.60 annualized dividend and a dividend yield of 2.26%. Walgreens Boots Alliance’s dividend payout ratio (DPR) is currently 44.20%.
Walgreens Boots Alliance declared that its board has approved a share buyback plan on Wednesday, October 25th that permits the company to repurchase $1.00 billion in outstanding shares. This repurchase authorization permits the pharmacy operator to purchase shares of its stock through open market purchases. Stock repurchase plans are typically an indication that the company’s leadership believes its shares are undervalued.
In other news, insider Stefano Pessina purchased 98,858 shares of Walgreens Boots Alliance stock in a transaction on Monday, January 15th. The shares were purchased at an average cost of $76.07 per share, for a total transaction of $7,520,128.06. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. 14.80% of the stock is owned by insiders.
A number of large investors have recently added to or reduced their stakes in the business. Hudock Capital Group LLC boosted its position in Walgreens Boots Alliance by 0.5% in the second quarter. Hudock Capital Group LLC now owns 1,306 shares of the pharmacy operator’s stock valued at $102,000 after buying an additional 6 shares in the last quarter. Northern Capital Management LLC raised its stake in shares of Walgreens Boots Alliance by 0.4% in the second quarter. Northern Capital Management LLC now owns 6,635 shares of the pharmacy operator’s stock worth $520,000 after acquiring an additional 25 shares during the last quarter. MAI Capital Management raised its stake in shares of Walgreens Boots Alliance by 0.6% in the second quarter. MAI Capital Management now owns 5,272 shares of the pharmacy operator’s stock worth $413,000 after acquiring an additional 34 shares during the last quarter. Girard Partners LTD. raised its stake in shares of Walgreens Boots Alliance by 1.9% in the second quarter. Girard Partners LTD. now owns 3,053 shares of the pharmacy operator’s stock worth $239,000 after acquiring an additional 56 shares during the last quarter. Finally, Summit Asset Management LLC raised its stake in shares of Walgreens Boots Alliance by 0.7% in the second quarter. Summit Asset Management LLC now owns 8,969 shares of the pharmacy operator’s stock worth $702,000 after acquiring an additional 59 shares during the last quarter. Hedge funds and other institutional investors own 60.82% of the company’s stock.
WARNING: This news story was published by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are reading this news story on another site, it was stolen and republished in violation of US and international trademark and copyright law. The legal version of this news story can be viewed at https://www.dispatchtribunal.com/2018/02/20/walgreens-boots-alliance-wba-given-a-94-00-price-target-at-royal-bank-of-canada.html.
About Walgreens Boots Alliance
Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.